Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.
about
Time-dependent effects of phenothiazines on dopamine turnover in psychiatric patientsConcentration gradients of monoamine metabolites in human cerebrospinal fluid.Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies.Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulationAmine metabolites in ventricular cerebrospinal fluid in coma.The history and future of probenecid.Transmitter precursors and metabolites in human ventricular cerebrospinal fluid.Failure of cerebrospinal fluid homovanillic acid to predict levodopa response in Parkinson's diseaseMelancholia, a model in madness: a discussion of recent psychobiologic research into depressive illness.Interaction in the cerebral metabolism of the biogenic amines. Effect of phenelzine on this interaction.Interaction in the cerebral metabolism of the biogenic amines. Effects of phenelzine on the cerebral metabolism of the 5-hydroxyindoles in dog brain.On the elimination of centrally formed 5-hydroxyindoleacetic acid by cerebrospinal fluid and urine.Amine metabolism in brainEffect of clomipramine on monoamine metabolites in the cerebrospinal fluid of behaviorally normal dogs.Effects of chlorpromazine on the metabolism of catecholamines in dog brain.Homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in serial samples of cerebrospinal fluid from the lateral ventricle of the dog.Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid of a child with familial dysautonomia.The transport of L-tryptophan from cerebrospinal fluid in the dog.Probenecid-induced accumulation of 5-hydroxyindoleacetic acid and homovanillic acid in rat brain.Origins of catecholamine metabolites in monkey cerebrospinal fluid.Inhibtion of the transport of 5-hydroxyindoleacetic acid from brain by ethanol.Radiometric assay of total tryptophan hydroxylation by intact cultured pineal glands.Penetration of 5-hydroxyindoleacetic acid across the blood-cerebrospinal fluid barrier.Pharmacological evidence for the existence of multiple functional pools of brain serotonin: analysis of brain perfusate from conscious rats.5-hydroxyindoleacetic acid in the brain and cerebrospinal fluid of the rabbit following administration of drugs affecting 5-hydroxytryptamine.Effects of chloral hydrate, gamma-butyrolactone, and equithesin on the efflux of dopamine and 5-hydroxytryptamine metabolites into cerebroventricular perfusates of rats.The effect of probenecid on the elimination from CSF of intraventricularly injected 5-hydroxyindolecetic acid in normal and hydrocephalic dogs.Relationship of monoamine metabolites in human cerebrospinal fluid to age.Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism.Passage of 5-hydroxytryptamine through the blood-brain barrier, its metabolism in the brain and elimination of 5-hydroxyindoleacetic acid from the brain tissue.
P2860
Q28339708-EF6204C9-2690-48E1-A704-0B83D865EE2BQ33756143-EF47EFC6-593F-4939-81B3-F5B2CEFF6EC0Q34185330-67DD74E9-66A0-4100-9838-E8E545F68746Q36024463-15446B5B-A217-429F-906C-9163917B2365Q36995256-2DE637D6-EE17-44AA-BF25-3F7E39D8BF9CQ37936912-7341A142-8948-4254-B837-3819607301AEQ39090090-F698C2D0-431F-4F2E-A258-492D4466143FQ39376713-954D4C03-570B-4ED0-87B5-6FC641B42A7BQ39936813-3B680ADC-BDFC-4CE0-954F-2C58FEF39BE8Q39994314-7D4D3554-5125-4D58-8BF7-EE7C4AAF782FQ39994461-762DFC53-6F95-443B-A1A7-3F681018F9CEQ41504693-F643BBFD-F74E-4AE0-AB25-6326879C0F43Q41959043-52E87958-7EEF-4B67-9C14-3AEF8D10F25EQ42940916-22838173-3E1A-4160-99DC-12E5FC1C1DADQ43119394-EA5E3E47-0FCA-4CD1-9AF2-00E888F8770BQ43246560-9C8E0E76-C156-46C4-95F8-40D07E7BE332Q44496744-93C3B1B1-5083-44EC-A043-4DF5B1DD2A7AQ44714151-3D81A71A-D830-434F-9BE8-FA928C48A1C2Q47987820-6A7C3FBE-7D39-4570-B132-6B650F9DD00DQ48218177-B9621549-FD48-493E-B0D1-9AB149E7A5D5Q48444356-68ABBFD1-4257-4B3B-A4B9-7EA56447E395Q48462429-9023A369-B1D1-449F-8F9B-A127152A5D9AQ48543291-DB03ABA8-60DC-4447-9588-589CA3A08081Q48686207-396F1861-DD39-4DE0-97D4-2D34457145ABQ48736367-7584E1F1-DAC2-45CF-948A-91ED584A1D45Q48915127-93995FC6-2132-474F-BE01-817CFF60E628Q48930820-2713824E-A5B8-4D84-BB4F-3EB83EC72CD2Q49134471-7412BECB-D1BD-40CA-B5D5-4758B4D9D764Q49146215-F4B5DBDC-CE64-48FB-83AF-8FA163DF26D3Q51160311-7E75331B-4E35-4AF8-92CA-24E41B8B103AQ51186322-A8322423-29D1-42C2-86AD-6C8376C11CDA
P2860
Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.
description
1966 nî lūn-bûn
@nan
1966年の論文
@ja
1966年学术文章
@wuu
1966年学术文章
@zh-cn
1966年学术文章
@zh-hans
1966年学术文章
@zh-my
1966年学术文章
@zh-sg
1966年學術文章
@yue
1966年學術文章
@zh
1966年學術文章
@zh-hant
name
Concentrations of 5-hydroxyind ...... ing treatment with probenecid.
@en
Concentrations of 5-hydroxyind ...... ing treatment with probenecid.
@nl
type
label
Concentrations of 5-hydroxyind ...... ing treatment with probenecid.
@en
Concentrations of 5-hydroxyind ...... ing treatment with probenecid.
@nl
prefLabel
Concentrations of 5-hydroxyind ...... ing treatment with probenecid.
@en
Concentrations of 5-hydroxyind ...... ing treatment with probenecid.
@nl
P2093
P1433
P1476
Concentrations of 5-hydroxyind ...... ing treatment with probenecid.
@en
P2093
Ashcroft GW
Crawford TB
Guldberg HC
P304
P356
10.1016/0024-3205(66)91026-5
P407
P577
1966-09-01T00:00:00Z